Our team of scientists have broad experience in drug development in various therapeutic areas. We provide a thorough assessment of programs for investors and capital venture companies or provide these services to perform due diligence on candidate assets. Additionally, we can prepare clients that are subject to a due diligence by potential investors to participate and put forward the best and most-balanced features of their program.

Inncelerex provides:

​

Assessment of strengths and weaknesses of the asset and solution to promote the asset's gap analysis

​

Identification of required investigations or studies

​

Assessment of the probability of technical and regulatory success

Potential differentiation strategies and creating differentiation of assets from competitor products

 

Competitor comparison in relation to predicted efficacy or safety differentiation of the asset